Ewing's sarcoma (ES) is one of the most malignant tumors of bone and soft tissue in children and younger adults.
Therefore, we performed RT-PCR using specific primers located on both sides of the gene to amplify different chimeric genes. 18) We also examined different solid tumor samples for the presence or absence of specific chimeric genes by using both agarose gel and Bioanalyzer. Specific chimeric genes were detected only in ES samples and were not detected in other tumor samples.
Here, we describe a rapid and simple method for the simultaneous detection of these specific genes in ESFT and its clinical applications. 11) KP-EW-MS, 16) and SCMC-ES1 16) ), 2 PNET cell lines (SK-N-MC, 16) SK-N-L0 16) ), and 1 NB cell line (IMR-32) were examined (Table 1) . They were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2 g/l sodium bicarbonate under 5% CO 2 at 37°C.
MATERIALS AND METHODS

Cell Lines and Tumor Samples 3 ES cell lines (NCR-
Twenty-three clinical tumor samples (3 ESs, 14 NBs, 2 RMSs, 1 ML, 1 Osteosarcoma (OS), 1 Osteochondroma, 1 Wilms' tumor) were examined ( Table 2 ). The tissues had been stored at Ϫ80°C since collection. The final diagnoses for these patients were made by the histopathological method. Informed consent was obtained from all patients before they entered the study.
RNA Extraction Total RNA from 6 cell lines and 23 clinical tumor samples was extracted by using TRIZOL reagent (GIBCO BAL), based on the acid guanidinium thiocyanate-phenol-chloroform extraction method. 19) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Total RNA (0.8 mg) was reverse transcribed in a 10 ml reaction mixture with a first strand cDNA synthesis kit (ReverTra Ace-a-TM , TOYOBO). PCR was carried out in a 10 ml reaction mixture containing 1.2 pmol of the respective primers (Table 3) , 11, 16, 20) with an mRNA Selective PCR Kit Ver. 1.1 (TaKaRa). Each primer was set at the outside of the breakpoint in the known chimeric gene. 18) PCR amplification was done in a Mastercycler personal (eppendorf) for 30 cycles. The first cycle consisted of denaturation at 85°C for 3 min, annealing at 57°C for 3 min, and extension at 72°C for 4 min; the next 29 cycles consisted of denaturation at 85°C for 1.5 min, annealing at 57°C for 1.5 min, and extension at 72°C for 2 min; after the last cycle, extension was continued for an additional 3 min at 72°C and 5 min at 4°C. We used glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal marker and the SK-N-MC, SK-N-L0, NCR-EW2, KP-EW-MS, and SCMC-ES1 cell lines as positive controls. The IMR-32 cell line was examined as a negative control.
Analyses of PCR Products The PCR products were electrophoresed through 3% Nusieve 3 : 1 agarose (BMA) gel, stained with Vistra Green (Amersham Pharmacia Biotech), and visualized under a UV lamp. Moreover, we used a Bioanalyzer (Agilent Technologies) to analyze these bands more accurately. The Bioanalyzer detects laser fluorescence using a LabChip in which a capillary is included, and has about a 5% coefficient of variation.
RESULTS AND DISCUSSION
We analyzed 6 cell lines (Table 1 ) and 23 clinical tumor samples (Table 2 ) for detecting the specific chimeric genes found in ES/PNET by using the RT-PCR technique. We show the results of electrophoresis and of Bioanalyzer (Figs. 1, 2). We can estimate an approximate band size from electrophoresis ( Fig. 2A) and determine an accurate band size by Bioanalyzer (Fig. 2B) . From the expected band sizes of the chimeric genes and GAPDH in the 6 cell lines, we found that the band sizes determined by Bioanalyzer were a little larger than the expected band sizes (Fig. 1) . Specific chimeric genes were detected in all ES tumor samples (T1-T3). However, we could not detect specific chimeric genes in other SRCT (T4-T20) or in other tumors (T21-T23). Therefore, the only tumors among the SRCT in which specific chimeric genes were found were ES.
The chimeric genes predicted from the band sizes determined by Bioanalyzer are shown in Table 5 (see the expected band sizes in Table 4 ). In particular, three chimeric genes (264 bp, 447 bp, and 481 bp) were detected in T2. In the electrophoresis of the T2 sample, two more extra-bands were detected. However, in Bioanalyzer for this case, these bands weren't detected, and even if we did once again, these bands weren't detected. Assuming that the chromosomal breakpoints occur in the introns, many combinations between EWS and ETS family genes are possible. When attempting to search for the combination that is amplified by each primer set in this situation, we found several possible combinations that would give rise to these three chimeric genes. Conse- T3  3y  M  ES  312  T4  1y  F  NB  ND  T5  9m  F  NB  ND  T6  9m  M  NB  ND  T7  8m  F  NB  ND  T8  9m  M  NB  ND  T9  3y  M  NB  ND  T10  8m  M  NB  ND  T11  4m  M  NB  ND  T12  10m  F  NB  ND  T13  6m  F  NB  ND  T14  6y  F  NB  ND  T15  7y  F  NB  ND  T16  8m  F  NB  ND  T17  9m  F  NB  ND  T18  3y  M  RMS  ND  T19  11y  F  RMS  ND  T20  6y  F  ML  ND  T21  13y  M  OS  ND  T22  12y  F  Osteochondroma  ND  T23 8m M Wilms' tumor ND ES: Ewing's sarcoma, NB: neuroblastoma, RMS: rhabdomyosarcoma, ML: malignant lymphoma, OS: osteosarcoma. ND: not detected. Tables 4, 5 ). Since it is unreliable to determine the combination between EWS and ETS family genes only from the band size, we need to confirm these predictions by using primers of EWS and specific ETS family genes, or by attempting direct sequencing. This patient (T2) was a case with recurrent lung metastasis after strong chemotherapy and resection, the patient's tumor sample was from the metastatic site, and heterogeneous tumor cells might be found in this tissue. T1 and T3 of the ES tumor samples showed bands at 261 bp and 312 bp, respectively, which fit predictions for several chimeric genes (Table 4) . After RT-PCR using appropriate primers (EWS and ERG primers for T1, and EWS and ETV1 primers for T3), we could detect specific chimeric genes involving EWS and ERG for T1, and EWS and ETV1 for T3. Therefore, it was thought that the 261 bp gene might be EWS (exon 7)-ERG (exon 9) (estimated gene size: 259 bp) (T1 wasn't amplified by the primers of EWS and FLI1) and that the 312 bp gene might be EWS (exon 7)-ETV1 (exon 11) (308 bp) ( Table 5 ). In T3, the possibility of EWS-ERG will be thought of, because we have finished using T3 tissue sample to analyze some chimeric genes and could not confirm the detailed combination of EWS-ETS.
Specific chimeric genes could be detected in all ES samples, but not in other SRCT or in OS (T21), Osteochondroma (T22), or Wilms' tumor (T23). This confirms that RT-PCR analysis is valid as a method to distinguish ES from SRCT. Although failure to detect chimeric genes in ESFT tumor samples may lead to false negative diagnoses, these genes occur in more than 95% of cases, 5) suggesting that this easy and rapid diagnostic method will be very useful.
It has been reported that patients with the specific EWS (exon 7)-FLI1 (exon 6) chimeric gene in tumor cells have a good prognosis. 17) As these three patients (T1, T2, T3) do not have this chimeric gene, they may have a poor prognosis. In the future, we intend to increase the number of ESFT clinical tumor samples studied in order to improve the reliability of diagnosis by this method. Moreover, we will investigate the clinical application of this method to detect tumor cell contamination in stem cells used for hematopoietic stem cell transplantation (autologous bone marrow transplantation and autologous peripheral blood stem cell transplantation). 
